Lin Li

11.9k citations
147 papers · 6.0k · 2 hit papers · h-index 39

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • NF-κB Signaling Pathways
  • Oncology top 2%

Papers in

    • RNA modifications and cancer 11
    • Circular RNAs in diseases 8
    • Cancer-related molecular mechanisms research 19
    • MicroRNA in disease regulation 14
    • NF-κB Signaling Pathways 7

Lin Li

140 papers receiving 5.9k citations

Lin Li's Hit Papers

Underestimated health risks: polystyrene micro- and nanoplastics jointly induce intestinal barrier dysfunction by ROS-mediated epithelial cell apoptosis 2021 · 357 citations
3570+4+8Years since publication250500750

Peers

Lin Li
Comparison fields: 5 of 134
  • Cancer Research 2.5k
  • Oncology 1.1k
  • Molecular Biology 2.9k
  • Immunology 750
  • Pollution 308
Replace Lixin Wei with:
Lixin Wei China
Jie Xu China
Chen Liang China
Glen Reid Australia
Xiaobo Li China
Jason Chesney United States
Xiao Xu China
Xiaoxu Wang China
Arthur A. Levin United States
Yu‐Sun Chang Taiwan
Lin Li relative to Lixin Wei China Lixin Wei's profile →
Citations per field
00.5×7.7×
Lixin Wei · 1×
Citations per year

Countries citing papers authored by Lin Li

Since Specialization
Citations

This map shows the geographic impact of Lin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Li more than expected).

Fields of papers citing papers by Lin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Li. The network helps show where Lin Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Lin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lin Li Line = papers co-authored together Lin Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
Hit paper breakdown →
2014890
2 2011377
3
Underestimated health risks: polystyrene micro- and nanoplastics jointly induce intestinal barrier dysfunction by ROS-mediated epithelial cell apoptosis
Hit paper breakdown →
2021357
4 1998275
5 2018196
6 2012168
7 2017167
8 1996161
9 2014110
10 2015103
11 201398
12 199997
13 201589
14 201287
15 201585
16 200084
17 202184
18 201776
19 202372
20 201671

About Lin Li

Lin Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 147 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (14 papers), RNA modifications and cancer (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), interferon and immune responses (8 papers), HIV Research and Treatment (8 papers), Circular RNAs in diseases (8 papers) and NF-κB Signaling Pathways (7 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (1.1k citations), Molecular Biology (2.9k citations), Immunology (750 citations) and Pollution (308 citations). Lin Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Warner C. Greene, George Demartino, Wangjun Liao, Cong Wu, Yanmei Han, Qiuyan Liu, Pin Wang, Xuetao Cao, Yiquan Xue and Sheng Xu. Their work appears in journals such as PLoS ONE, Oncotarget, Journal of Clinical Oncology, Oncogene and Journal of Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact